Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Division of Dermatology, University of California, San Diego, California.
Dermatol Surg. 2020 Feb;46(2):240-246. doi: 10.1097/DSS.0000000000002086.
Facial aging is a multifactorial process. Accordingly, expert opinion has largely been unanimous in that multimodal treatment targeting various aspects of the aging face provides superior results. However, there is a lack of studies exploring patient response.
To compare patient retention between triple multimodal facial rejuvenation treatment (neuromodulator, filler, and energy-based therapy) and monotherapy (neuromodulator alone).
A retrospective, multicenter (the United States, Canada, and Germany) study was performed. Cases were retrieved from July 2015 to June 2016. The study compared patients who had undergone monotherapy (neuromodulator), combined multimodal treatment (neuromodulator, filler, and energy-based therapy on the same day), and sequential multimodal treatment (neuromodulator, filler, and energy-based therapy over a 1-year period). Retention rates were calculated.
A total of 509 patients were included: monotherapy (300), sequential multimodal treatment (93), and combined multimodal treatment (116). Patient retention was significantly higher in the combined multimodal treatment group compared with the monotherapy and sequential multimodal treatment groups (p < .001). Subgroup analysis revealed similar trends at all sites.
Based on retention rates, patients are more likely to return to the clinic when multiple treatment modalities are used during 1 encounter. These data further solidify the importance of multimodal therapy for both the provider and the patient.
面部衰老过程是多因素的。因此，专家们普遍认为，针对面部衰老各个方面的多模态治疗可提供更优的效果。然而，目前缺乏对患者反应的研究。
比较三重多模态面部年轻化治疗（神经调节剂、填充剂和基于能量的疗法）与单药治疗（仅神经调节剂）的患者保留率。
这是一项回顾性、多中心（美国、加拿大和德国）研究。病例取自 2015 年 7 月至 2016 年 6 月。该研究比较了接受单药治疗（神经调节剂）、联合多模态治疗（神经调节剂、填充剂和基于能量的疗法同日进行）和序贯多模态治疗（神经调节剂、填充剂和基于能量的疗法在 1 年内进行）的患者。计算保留率。
共纳入 509 例患者：单药治疗组（300 例）、序贯多模态治疗组（93 例）和联合多模态治疗组（116 例）。联合多模态治疗组的患者保留率明显高于单药治疗组和序贯多模态治疗组（p＜.001）。亚组分析显示所有地点均存在类似趋势。
基于保留率，当在 1 次就诊中使用多种治疗方式时，患者更有可能返回诊所。这些数据进一步巩固了多模态治疗对提供者和患者的重要性。
